HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vickie King Selected Research

oclacitinib

7/2022Speed of onset of a new chewable formulation of oclacitinib maleate (Apoquel®) in a canine model of IL-31-induced pruritus.
3/2022Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vickie King Research Topics

Disease

2Atopic Dermatitis (Atopic Eczema)
07/2022 - 03/2022
2Infections
10/2014 - 06/2013
1Pruritus (Itching)
07/2022
1Dermatitis
07/2022
1Lyme Disease (Disease, Lyme)
07/2015
1Latent Infection
05/2014
1Leptospirosis
06/2013

Drug/Important Bio-Agent (IBA)

2maleic acid (maleate)IBA
07/2022 - 03/2022
2oclacitinibIBA
07/2022 - 03/2022
2TabletsIBA
07/2022 - 03/2022
2VaccinesIBA
06/2013 - 06/2013
1Doxycycline (Periostat)FDA LinkGeneric
07/2015
1cefovecinIBA
07/2015
1Amoxicillin (Wymox)FDA LinkGeneric
07/2015
1Anti-Bacterial Agents (Antibiotics)IBA
07/2015
1Immunologic Factors (Immunomodulators)IBA
10/2014
1DNA (Deoxyribonucleic Acid)IBA
05/2014

Therapy/Procedure

1Oral Administration
07/2015